Related Experiment Videos
Bioreactors for hematopoietic cell culture
1Department of Chemical Engineering, University of Queensland, Brisbane, Queensland 4072, Australia. LarsN@cheque.uq.edu.au
Annual Review of Biomedical Engineering
|November 10, 2001
Summary
Hematopoietic cell expansion, or ex vivo culture, shows promise for bone-marrow transplants and therapies. Despite complex cell interactions and dynamic environments, bioreactor-produced cell products are advancing clinical applications.
Area of Science:
- Biotechnology and Regenerative Medicine
- Cell Biology and Hematology
Background:
- Hematopoietic cell culture, also known as ex vivo expansion, is crucial for various medical applications.
- These cultures are inherently complex due to diverse cell types, developmental stages, and dynamic interactions.
Purpose of the Study:
- To highlight the potential of ex vivo hematopoietic cell expansion.
- To underscore the challenges and recent advancements in hematopoietic cell culture technologies.
Main Methods:
- The abstract discusses the complexity of hematopoietic cultures, including cell interactions via cytokines and adhesion molecules.
- It mentions the metabolic interactions within these complex cellular environments.
Main Results:
- Cell products generated in bioreactors have demonstrated promising outcomes in early-phase clinical trials.
- These results indicate the feasibility and potential of advanced cell culture techniques.
Conclusions:
- Ex vivo expansion of hematopoietic cells is a key enabling technology for numerous therapeutic areas.
- Despite significant biological and technical challenges, bioreactor-based cell production is progressing towards clinical utility.